Quantcast

Latest Prime Therapeutics Stories

2014-09-17 16:27:25

ST. PAUL, Minn., Sept. 17, 2014 /PRNewswire/ -- The United States doesn't have a singular prescription drug problem, we have a series of challenges related to safety, efficacy and cost, according to Peter Wickersham, senior vice president for Integrated Care and Specialty at Prime Therapeutics LLC (Prime). Wickersham will deliver a keynote address, "Solving America's Drug Problem," at the Managed Markets Summit in Scottsdale, Ariz., on Sept. 19, 2014. "Opinions may vary on the causes,...

2014-09-08 16:25:38

ST. PAUL, Minn., Sept. 8, 2014 /PRNewswire/ -- Prime Therapeutics, LLC (Prime) has submitted comments to the U.S. Food and Drug Administration (FDA) in support of two citizen petitions on the naming of biosimilar drugs. Biosimilars are medically equivalent versions of biologics, used to treat complex illnesses such as cancer. The citizen petitions were filed in 2013 by the Generic Pharmaceutical Association (GPhA) and Novartis. The petitions urged the FDA to adopt a naming system...

2014-08-27 23:10:48

Catamaran’s BriovaRx Specialty Pharmacy and Diplomat Pharmacy, Inc.’s Diplomat University were the two winners of Specialty Pharmacy Solutions’ Innovation Competition, announces the company’s founder and Principal Consultant Bill Sullivan in the August issue of Atlantic Information Services’s Specialty Pharmacy News. Prime Therapeutics received an honorable mention. Washington, DC (PRWEB) August 27, 2014 Catamaran’s BriovaRx Specialty Pharmacy and Diplomat Pharmacy, Inc.’s...

2014-06-17 08:30:17

Despite shift in generics and other less expensive traditional drugs, specialty drug costs drive net ingredient cost and overall commercial pharmacy spend increases ST. PAUL, Minn., June 17, 2014 /PRNewswire/ -- To help make medicine more affordable for the 25 million members it serves, Prime Therapeutics LLC (Prime) starts with delivering an industry-low net cost per prescription*. In 2013, Prime's average net ingredient cost per prescription was $58.99, according to its 2014 Report on...

2014-04-29 08:37:09

ST. PAUL, Minn., April 29, 2014 /PRNewswire/ -- For a second year, Prime Therapeutics LLC (Prime) received top rating for overall customer satisfaction and most likely to recommend for larger pharmacy benefit managers (PBMs) according to a survey conducted by the Pharmacy Benefit Management Institute (PBMI). The top ranking recognized Prime's efforts to help employers get the best value and experience with their health care dollars. The survey included responses from 394 U.S. plan...

2014-04-04 08:25:37

ST. PAUL, Minn., April 4, 2014 /PRNewswire/ -- Patrick Gleason, Pharm.D., director of health outcomes at Prime Therapeutics LLC (Prime), has been awarded the Academy of Managed Care Pharmacy (AMCP) Spirit of Volunteerism Award for 2014. Dr. Gleason accepted the award on April 2 at the Annual Awards Dinner during its 26(th) Annual Meeting and Expo in Tampa, Fla. The annual awards ceremony recognizes outstanding members for their significant contributions to managed care pharmacy and...

2014-04-03 08:30:59

Company expands from 100 to 800 employees in one decade IRVING, Texas and ST. PAUL, Minn., April 3, 2014 /PRNewswire/ -- Today, Prime Therapeutics LLC (Prime) celebrated its expansion from 100 employees to 800 employees in the 10 years it has been located in Irving, Texas. Irving Mayor Beth Van Duyne joined Eric Elliott, president and CEO of Prime, to celebrate its 10-year anniversary and continued growth in Irving. In April 2004, Prime, a leading pharmacy benefits management...

2014-04-03 08:30:57

Coordinating Benefits, Customizing Care Management Programs and Providing Member Support Associated with Improved Adherence to Multiple Sclerosis (MS), Autoimmune, and Oral Oncology Drugs ST. PAUL, Minn., April 3, 2014 /PRNewswire/ -- Receiving specialty drugs through Prime Therapeutics Specialty Pharmacy LLC rather than a retail pharmacy store is associated with improved adherence to these medicines, according to a new study by Prime Therapeutics LLC (Prime). The study, which...

2014-04-02 08:34:06

ST. PAUL, Minn., April 2, 2014 /PRNewswire/ -- Pharmacy plan members with specialty drug out-of-pocket costs (OOP) less than $250 are more likely to start taking their medication than those with higher OOP. This finding is according to a new study presented by Prime Therapeutics LLC (Prime) at the Academy of Managed Care Pharmacy (AMCP) 26th Annual Meeting & Expo in Tampa, Fla. Increasing member out-of-pocket costs is a common strategy for controlling escalating costs of...

2014-04-01 08:30:10

Rate of high risk use low among commercially insured ST. PAUL, Minn., April 1, 2014 /PRNewswire/ -- People who are at high-risk for opioid abuse use had significantly higher total medical costs ($19,513 vs. $5,493) than those who were not at high risk according to a new study by Prime Therapeutics (Prime). The Centers for Medicare & Medicare Services (CMS) defines high risk as "using a daily morphine equivalent dose (MED) of greater than 120 mg for at least 90 consecutive days,...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related